Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis

Nature Reviews Nephrology

Volumn 7, Issue 2, 2011, Pages 85-95

  Lien, Yeong Hau H ^a   Lai, Li Wen ^b  

^a Arizona Kidney Disease and Hypertension Center   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GEMCITABINE; IMATINIB; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERFERON; INTERLEUKIN 13; MITOMYCIN C; NEUTROPHIL CYTOPLASMIC ANTIBODY; PAMIDRONIC ACID; PREDNISONE; RIBAVIRIN; RITUXIMAB; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; BRONCHUS CARCINOID; CANCER CHEMOTHERAPY; CANCER SURGERY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CRYOGLOBULINEMIA; CUTANEOUS T CELL LYMPHOMA; CYTOKINE RELEASE; DISEASE ASSOCIATION; FOCAL GLOMERULOSCLEROSIS; GENE OVEREXPRESSION; GLOMERULONEPHRITIS; GRAFT VERSUS HOST REACTION; HAIRY CELL LEUKEMIA; HEMATOLOGIC MALIGNANCY; HEPATITIS C; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; IDIOPATHIC DISEASE; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; MIXED MYELODYSPLASTIC MYELOPROLIFERATIVE DISEASE; MYELOPROLIFERATIVE DISORDER; NEPHROTIC SYNDROME; PARANEOPLASTIC GLOMERULONEPHRITIS; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REVIEW; SOLID TUMOR; TH2 CELL; THROMBOTIC THROMBOCYTOPENIC PURPURA; THYMOMA;

GLOMERULONEPHRITIS; HUMANS; NEOPLASMS; PARANEOPLASTIC SYNDROMES;

EID: 79551571079     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.171     Document Type: Review

References (118)

1. Ronco, R M. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 56, 355-377 (1999).
2. Lee, J. C, Yamauchi, H. & Hopper, J. Jr. The association of cancer and the nephrotic syndrome. Ann. Intern. Med. 64, 41-51 (1966).
3. Bacchetta, J., Juillard, L, Cochat, P. & Droz, J. R Paraneoplastic glomerular diseases and malignancies. Crit. Rev. Oncol. Hematol. 70, 39-58 (2009).
4. Chiu, K. C. et al. Paraneoplastic polymyositis associated with crescentic glomerulonephritis. Ren. Fail. 30, 939-942 (2008).
5. Nunez, S. et al. Association between scleroderma, renal cell carcinoma and membranous nephropathy. Clin. Nephrol. 71, 63-68 (2009).
6. Arenas, M. D. et al. Nephrotic syndrome as paraneoplastic manifestation of a primary pulmonary lymphoepi the lioma-like carcinoma. Clin. Nephrol. 72, 206-210 (2009).
7. Mimura, I., Tojo, A., Kinugasa, S., Uozaki, H. & Fujita. T. Renal cell carcinoma in association with IgA nephropathy in the elderly. Am. J. Med. Sci. 338, 431-432 (2009).
8. Lefaucheur, C. et al. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 70, 1510-1517 (2006).
9. Beaufils, H., Jouanneau, C. & Chomette, G. Kidney and cancer: results of immunofluorescence microscopy. Nephron 40, 303-308 (1985).
10. Pascal, R. R., lannaccone, P M., Rollwagen, F. M., Harding, T. A. & Bennett, S. J. Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer patients. Cancer Res. 36, 43-47 (1976).
11. Ohtani, H. et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol. Dial. Transplant. 19, 574-579 (2004).
12. Holdsworth, S. R., Kitching, A. R. & Tipping, P G. Thl and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int. 55, 1198-1216 (1999).
13. Tipping, P.G. & Kitching, A. R. Glomerulonephritis, Th1 and Th2: what's new? Clin. Exp. Immunol. 142, 207-215 (2005).
14. Taniguchi, K. et al. Rectal cancer with paraneoplastic nephropathy: association of vascular endothelial growth factor. Dig. Surg. 21, 455-457 (2004).
15. Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707-716 (2003).
16. Cheong, H. I. et al. Circulating VEGF and TGF-betal in children with idiopathic nephrotic syndrome. J. Nephrol. 14, 263-269 (2001).
17. Ahmed, M., Solangi, K., Abbi, R. & Adler, S. Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor-associated glomerulonephritis. J. Am. Soc. Nephrol. 8, 848-852 (1997).
18. Sartelet, H. et al. Membranoproliferative glomerulonephritis (MPGN) and pulmonary carcinoid tumour. Nephrol. Dial. Transplant. 12, 2405-2406 (1997).
19. Ahmed, M. S., Wong, C. F & Abraham, K. A. Membrano-proliterative glomerulonephritis associated with metastatic prostate carcinoma-should immunosuppressive therapy be considered? Nephrol. Dial. Transplant. 23, 777(2008).
20. Reshi, A. R., Mir, S. A., Gangoo, A. A., Shah, S. & Banday, K. Nephrotic syndrome associated with transitional cell carcinoma of urinary bladder. Scand. J. Urol. Nephrol. 31, 295-296 (1997).
21. Biava, C. G., Gonwa, T. A., Naughton, J. L. & Hopper, J. Jr. Crescentic glomerulonephritis associated with nonrenal malignancies. Am. J. Nephrol. 4, 208-214 (1984).
22. Tatsis, E., Reinhold-Keller, E., Steindorf, K., Feller, A. C. & Gross, W. L. Wegener's granulomatosis associated with renal cell carcinoma. Arthritis Rheum. 42, 751-756 (1999).
23. Pankhurst, T, Savage, C. O., Gordon, C. & Harper, L. Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43, 1532-1535 (2004).
24. Faurschou, M. et al. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J. Rheumatol. 35, 100-105 (2008).
25. Edgar, J. D., Rooney, D. R, McNamee, P & McNeill, T. A. An association between ANCA positive renal disease and malignancy. Clin. Nephrol. 40, 22-25 (1993).
26. Hruby, Z., Bronowicz, A., Rabczynski, J., Kopec, W. & Szewczyk, Z. A case of severe anti-neutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis and asymptomatic gastric cancer. Int. Urol. Nephrol. 26, 579-586 (1994).
27. Baschinsky, D. Y., Baker, P B., Niemann, T. H. & Wilmer, W. A. Pauci-immune ANCA-positive crescentic glomerulonephritis associated with metastatic adenocarcinoma of the lung. Am. J. Kidney Dis. 36, E24 (2000).
28. Diez-Porres, L. et al. ANCA-associated vasculitis as paraneoplastic syndrome with colon cancer: a case report. Lupus 14, 632-634 (2005).
29. Mustonen, J., Pasternack, A. & Helin, H. IgA mesangial nephropathy in neoplastic diseases. Contrib. Nephrol. 40, 283-291 (1984).
30. Magyarlaki, T. et al. Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron 82, 127-130 (1999).
31. Pertuiset, E. et al. Adult Henöch-Schonlein purpura associated with malignancy. Seinin. Arthritis Rheum. 29, 360-367 (2000).
32. Tsai, H. M. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. Hematol. Oncol. Clin. North Am. 21, 609-632 (2007).
33. Werner, T. L, Agarwal, N., Carney, H. M. & Rodgers, G. M. Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am. J. Hematol. 82, 295-298 (2007).
34. Zheng, X. L, Kaufman, R. M., Goodnough, L. T. & Sadler, J. E. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 103, 4043-4049 (2004).
35. Francis, K. K., Kalyanam, N., Terrell, D. R., Vesely, S. K. & George, J. N. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases. Oncologist 12, 11-19 (2007).
36. Mallouk, A., Pham, P. T. & Pham, P. C. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin. Exp. Nephrol. 10, 284-289 (2006).
37. Audard, V. et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 69, 2251-2260 (2006).
38. Ramirez, G., Stinson, J. B., Zawada, E. T. & Moatamed, F. IgA nephritis associated with mycosis fungoides. Report of two cases. Arch. Intern. Med. 141, 1287-1291 (1981).
39. Bajel. A. et al. IgA nephropathy associated with cutaneous T cell lymphoma. Leuk, Lymphoma 50, 2083-2085 (2009).
40. Douglas, M. F., Schwartz, M. M. & Sharon, Z. Cryoglobulinemia and immune-mediated glomerulonephritis in association with hairy cell leukemia. Am. J. Kidney Dis. 6, 181-184 (1985).
41. Abboud, I. et al. A paraneoplastic membrano proliferative glomerulonephritis with isolated C3 deposits associated with hairy cell leukaemia. Nephrol. Dial. Transplant. 25, 2026-2028 (2010).
42. Küppers, R., Schwering, I., Bräuninger, A., Rajewsky, K. & Hansmann, M. L. Biology of Hodgkin's lymphoma. Ann. Oncol. 13 (Suppl. 1), 11-18 (2002).
43. Ohshima, K. et al. lnterleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis. Histopathology 38, 368-375 (2001).
44. Lai, K. W. et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J. Am. Soc. Nephrol. 18, 1476-1485 (2007).
45. Da'as, N. et al. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur. J. Haematol. 67, 158-164 (2001).
46. Favre, G. et al. Membranoproliferative glomerulonephritis, chronic lymphocytic leukemia, and cryoglobulinemia. Am. J. Kidney Dis. 55, 391-394 (2010).
47. Mazzaro, C. et al. Hepatitis C virus risk: a hepatitis C virus related syndrome. J. Intern. Med. 247, 535-545 (2000).
48. Matignon, M. et al. Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore) 88, 341-348 (2009).
49. Saadoun, D., Resche-Rigon, M., Thibault, V, Piette, J. C. & Cacoub, R Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum. 54, 3696-3706 (2006).
50. Cacoub, P., Delluc, A., Saadoun, D., Landau, D. A. & Sene, D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann. Rheum. Dis. 67, 283-287 (2008).
51. Moulin, B. et al. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int. 42, 127-135 (1992).
52. Evans, D. J., Macanovic, M., Dunn, M. J. & Pusey, C. D. Membranous glomerulonephritis associated with follicular B-cell lymphoma and subepithelial deposition of IgGl-kappa paraprotein. Nephron Clin. Pract. 93, c2112-c118 (2003).
53. Papadavid, E. et al. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sezary syndrome. Br. J. Dermatol. 148, 709-718 (2003).
54. Dosa, S. et al. Acute myelomonocytic leukemia associated with nephrotic syndrome. A case report with immunological studies. Nephron 34, 125-129 (1983).
55. Levi, I., Dinour, D., Ben-Bassat, I. & Raanani, P Acute myeloid leukemia associated with nephrotic syndrome: case report and literature review. Leuk. Lymphoma 43, 1133-1136 (2002).
56. Sahiner, S., Ayli, M. D., Yuksel, C, Oneg, K. & Abayli, E. Membranous nephropathy associated with acute myeloid leukemia. Transplant. Proc. 36, 2618-2619 (2004).
57. Klco, J. M., Vij, R., Kreisel, F H., Hassan, A. & Frater, J. L. Molecular pathology of myeloproliferative neoplasms. Am. J. Clin. Pathol. 133, 602-615 (2010).
58. Komrokji, R. S., Zhang, L. & Bennett, J. M. Myelodysplastic syndromes classification and risk stratification. Hematol. Oncol. Clin. North Am. 24, 443-457 (2010).
59. Plomley, R. F et al. Polycythemia vera and glomerulonephritis. Aust. NZ J. Med. 13, 125-129 (1983).
60. Au, W. Y. Chan, K. W., Lui. S. L., Lam, C. C. & Kwong, Y L. Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders. Am. J. Kidney Dis. 34, 889-893 (1999).
61. Kaygusuz, I. et al. Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis. Ren. Fail. 32, 273-276 (2010).
62. Gersuk, G. M., Carmel, R. & Pattengale, R K. Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders. Blood 74, 2330-2334 (1989).
63. Floege, J., Eitner, F & Alpers, C. E. A new look at platelet-derived growth factor in renal disease. J. Am. Soc. Nephrol. 19, 12-23 (2008).
64. Haraguchi, K. et al. Focal segmental glomerulosclerosis associated with essential thrombocythemia. Clin. Exp. Nephrol. 10, 74-77 (2006).
65. Kosch, M. et al. Focal sclerosis with tip lesions secondary to polycythaemia vera. Nephrol. Dial. Transplant. 15, 1710-1711 (2000).
66. Okuyama, S. et al. Focal segmental glomerulosclerosis associated with polycythemia vera: report of a case and review of the literature. Clin. Nephrol. 68, 412-415 (2007).
67. Sudholt, B. A. & Heironimus, J. D. Chronic myelogenous leukemia with nephrotic syndrome. Arch. Intern. Med. 143, 168-169 (1983).
68. Gago, E. S., Luño, E., Quiñones, L., Jonte, F., & Alvarez, J. Chronic myelogenous leukemia and glomerulonephritis: report of a new case. Am. J. Med. 81, 1121-1122 (1986).
69. Majdan, M. et al. Chronic myelogenous leukaemia associated with rapidly progressive glomerulonephritis. Nephrol. Dial. Transplant. 9, 562-563 (1994).
70. Dwyer, J. P. et al. Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapy. Clin. Nephrol. 67, 176-181 (2007).
71. Saitoh, T. et al. Myelodysplastic syndromes with nephrotic syndrome. Am. J. Hematol. 60, 200-204 (1999).
72. Enright, H. et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br. J. Haematol. 91, 403-408 (1995).
73. Voulgarelis, M., Giannouli, S., Ritis, K. & Tzioufas, A. G. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur. J. Clin. Invest. 34, 690-700 (2004).
74. Paydas, S., Paydas, S., Tuncer, I., Zorludemir, S. & Gonlusen, G. A case with membranous glomerulonephritis and myelodysplastic syndrome. Nephron 62, 231-232 (1992).
75. Bogdanovic, R. et al. Glomerular involvement in myelodysplastic syndromes. Pediatr. Nephrol. 16, 1053-1057 (2001).
76. Nishida, M. et al. Focal segmental glomerulosclerosis in a girl with myelodysplastic syndrome. Nephrol. Dial. Transplant. 19, 2639-2641 (2004).
77. Morschhauser, F. et al. Glomerular injury in chronic myelomonocytic leukemia. Leuk. Lymphoma 18, 479-483 (1995).
78. Mok, C. C., Tarn, S. C. & Kwong, Y L. Pseudonephrotic syndrome caused by lysozymuria. Ann. Intern. Med. 121, 818(1994).
79. Enriquez, R. et al. Severe renal complications in chronic myelomonocytic leukemia. J. Nephrol. 21, 609-614 (2008).
80. Karras, A., de Montpreville, V., Fakhouri, F, Grünfeld, J. P & Lesavre, P. Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol. Dial. Transplant. 20, 1075-1082 (2005).
81. Hirokawa, K. et al. Age-related hyperplasia of the thymus and T-cell system in the Buffalo rat. Immunological and immunohistological studies. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 59, 38-47 (1990).
82. Nakamura, T. et al. The effect of thymectomy on the development of nephropathy in spontaneous thymoma rats of the BUF/Mna strain. Clin. Exp. Immunol. 71, 350-352 (1988).
83. Le Berre, L. et al. Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int. 68, 2079-2090 (2005).
84. Shalhoub, R. J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2, 556-560 (1974).
85. Le Berre, L. et al. Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J. Am. Soc. Nephrol. 20, 57-67 (2009).
86. Otani, M., Shimojo, H., Shiozawa, S. & Shigematsu, H. Renal involvement in bone marrow transplantation. Nephrology (Carlton) 10, 530-536 (2005).
87. Sahni, V., Choudhury, D. & Ahmed, Z. Chemotherapy-associated renal dysfunction. Nat. Rev. Nephrol. 5, 450-462 (2009).
88. Lesesne, J. B. et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J. Clin. Oncol. 7, 781-789 (1989).
89. Humphreys, B. D. et al. Gemcitabine-associated thrombotic microangiopathy. Cancer 100, 2664-2670 (2004).
90. Gurevich, F. & Perazella, M. A. Renal effects of anti-angiogenesis therapy: update for the internist. Am. J. Med. 122, 322-328 (2009).
91. Markowitz, G. S. et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J. Am. Soc. Nephrol. 12, 1164-1172 (2001).
92. Shah, M. et al. Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer 83, 1938-1946 (1998).
93. Mutluay, R. et al. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia. Clin. Nephrol. 70, 527-531 (2008).
94. Vilayur, E., Trevillian, P., Walsh, M. Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia. Nat. Clin. Pract. Nephrol. 5, 54-58 (2009).
95. Yang, A. H. et al. The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy. Nephrol. Dial. Transplant. 24, 3419-3425 (2009).
96. Alshayeb, H. & Wall, B. Non-Hodgkin's lymphoma associated membranoproliferative glomerulonephritis: rare case of long term remission with chemotherapy: a case report. Cases J. 2, 7201(2009).
97. Herrman, J. & Gabriel, F. Membranoproliferative glomerulonephritis in a patient with hairy-cell leukemia treated with alpha-II interferon. N. Engl. J. Med. 316, 112-113 (1987).
98. Moe, S. M., Baron, J. M., Coventry, S., Dolan, C. & Umans, J. G. Glomerular disease and urinary Sezary cells in cutaneous T-cell lymphomas. Am. J. Kidney Dis. 21, 545-547 (1993).
99. Navarro-Antolin, J. et al. Rapidly progressive fibrillary glomerulonephritis and cutaneous T-cell lymphoma. Nephron 73, 107-108 (1996).
100. Cather, J. C, Jackow, C, Yegge, J., Hagemeister, F. & Duvic, M. Mycosis fungoides with focal segmental glomerular sclerosis and nephrotic syndrome. J. Am. Acad. Dermatol. 38, 301-305 (1998).
101. Sato, M., Sohara, M., Kitamura. Y., Hatamochi, A. & Yamazaki, S. Ichthyosiform mycosis fungoides: report of a case associated with IgA nephropathy. Dermatology 210, 324-328 (2005).
102. Springate, J. E., Brecher, M., Brentjens, J. & Feld, L. G. Glomerulonephritis and chronic myelogenous leukemia. Child Nephrol. Urol. 9, 298-300 (1988).
103. Kanauchi, M., Dohi, K., Shiiki, H., Fujii, Y. & Ishikawa, H. Henoch-Schönlein purpura nephritis associated with polycythemia vera. Intern. Med. 33, 36-40 (1994).
104. Sharma, R. K. et al. Focal segmental glomerulosclerosis in a patient with polycythemia rubra vera. Nephron 69, 361(1995).
105. Kasuno, K. et al. IgA nephropathy associated with polycythaemia vera: accelerated course. Nephrol. Dial. Transplant. 12, 212-215 (1997).
106. Oymak, O. et al. Polycythemia vera presenting with rapidly progressive glomerulonephritis and pyoderma gangrenosum. Nephron 86, 346-347 (2000).
107. Chung, J., Park, P G. & Song, K. I. IgA nephropathy in a patient with polycythemia vera. Clinical manifestation of chronic renal failure and heavy proteinuria. Am. J. Nephrol. 22, 397-401 (2002).
108. Asaba, K. et al. Fibrillary glomerulonephritis associated with essential thrombocytosis. Clin. Exp. Nephrol. 7, 296-300 (2003).
109. Perazella, M. A. & Buller, G. K. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Am. J. Nephrol. 14, 223-225 (1994).
110. Liu, T. T, Chen, J. B., Chen, W. J., Kuo, C. Y & Lee, C. T. Idiopathic myelofibrosis associated with renal extramedullar hematopoiesis and nephrotic syndrome: case report. Chang Gung Med. J. 23, 169-174 (2000).
111. Pamuk, O. N. et al. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Leuk. Lymphoma 43, 661-663 (2002).
112. Kornblihtt, L. I. et al. Primary myelofibrosis in a patient who developed primary biliary cirrhosis, autoimmune hemolytic anemia and fibrillary glomerulonephritis. Ann. Hematol. 87, 1019-1020 (2008).
113. Komatsuda, A. et al. Crescentic glomerulonephritis accompanied by myel operoxidase-antineutrophil cytoplasmic antibodies in a patient having myelodysplastic syndrome with trisomy 7. Am. J. Kidney Dis. 31, 336-340 (1998).
114. Apostolou, T. et al. Atheroembolic renal disease and membranous nephropathy, in a patient with myelodysplastic syndrome, eosinophilia, and trisomy 8. Nephrol. Dial. Transplant. 17, 1336-1338 (2002).
115. Lee, H. C., Cheng, Y F., Chuang, F. R., Chen, J. B. & Hsu, K. T. Minimal change nephrotic syndrome associated with malignant thymoma: case report and literature review. Chang Gung Med. J. 24, 576-581 (2001).
116. Parambil, J. G., Keogh, K. A., Fervenza, F C. & Ryu, J. H. Microscopic polyangiitis associated with thymoma, exacerbating after thymectomy. Am. J. Kidney Dis. 48, 827-831 (2006).
117. Chung, S. et al. Simultaneous and sustained remission of intractable myasthenia gravis and focal segmental glomerulosclerosis with tacrolimus treatment. Clin. Nephrol. 70, 59-61 (2008).
118. Prasad, K. R, Alahakoon, D. G. & Vidanagama, U. Case of generalised myasthenia gravis with membranous nephropathy. Ceylon Med. J. 53, 25-26 (2008).